# Envarsus XR Compared to Immediate Release Tacrolimus

> **NCT03979365** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 261 (actual)

## Conditions studied

- Kidney Transplant Recipients

## Interventions

- **DRUG:** Envarsus XR
- **DRUG:** Tacrolimus twice daily

## Key facts

- **NCT ID:** NCT03979365
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-18
- **Primary completion:** 2022-03-29
- **Final completion:** 2022-03-29
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03979365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03979365, "Envarsus XR Compared to Immediate Release Tacrolimus". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03979365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*